Home / Import refusals / 799-2046163-2/10003/1

FDA Import Refusal 799-2046163-2/10003/1 — Pfizer Canada

Pfizer Canada — FEI 3002670556

The FDA refused shipment 799-2046163-2/10003/1 from Pfizer Canada (Canada) on December 18, 2025. The refused product falls under Drugs and Biologics — APIXABAN (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 18, 2025
Country
Canada
Product Category
Drugs and Biologics
Product Code
61LCA44 APIXABAN (ANTI-COAGULANT)
Charges
75

Other import refusals

  • SCS-6464414-6/10002/1 (Wed May 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5726966-3/10002/1 (Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0097204-1/10003/1 (Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9054875-9/10003/1 (Fri Jan 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8576098-3/43/1 (Wed Jun 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources